BPRRX Company Profile and Key Details

Boston Partners Long/Short Research Fd Inv Cl (NASDAQ:BPRRX) closed at $14.27 USD, gaining $0.10 (0.71%) from the previous close of $14.17. The stock is currently within 5% of its 52-week high $13.00 and $14.91. With a market capitalization of about $592.12 million, Boston Partners Long/Short Research Fd Inv Cl is classified as a small-cap and shows lower-than-market volatility (beta ~0.46). Headquartered in New York, NY, Boston Partners Long/Short Research Fd Inv Cl operates in the Financial Services sector and the Asset Management industry. The Fund seeks to provide long-term capital apprecThe Fund will invest, both long and short, in equity securities issued by large-, mid- and small-cap companies, as well as other instruments that are convertible into equity securities.

Boston Partners Long/Short Research Fd Inv Cl last paid a dividend of 1.5 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

Our AI price prediction model suggests that Boston Partners Long/Short Research Fd Inv Cl stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

Valuation shows Boston Partners Long/Short Research Fd Inv Cl trading at a premium to the broader market with a P/E of 59.04.

Boston Partners Long/Short Research Fd Inv Cl trades at a P/E ratio of 59.04, slightly above the S&P 500 average, with a price-to-sales ratio of 7.24 The P/FCF stands at -13.0, also below market averages.